Company / Inventory
Moderna Inventory History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$153.0M
FY2025
5-year range
$117.0M / $1.4B
FY2021-FY2025
Trend
+30.8%
vs FY2024
Sector context
#34 of 105
Health Care
What the data says
At $153M, Moderna's inventory ranks #34 of 105 in the Health Care sector. Inventory returned to growth in FY2025 after 3 years of decline, reaching $153M.
Based on SEC 10-K filings.
$153M in FY2025 with a 5-year CAGR of +26.6%.
Declined from $202M to $153M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -45.6%
- 5-Year CAGR
- +26.6%
- 10-Year CAGR
- -
Sector benchmark
#34 of 105 in Health CareTop 32% of 105This company $153.0M Sector average $885.3M
▼
-82.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +26.6%, indicating consistent growth.
- In FY2025, inventory increased 30.8% year-over-year.
- Ranks #34 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $153.0M | +30.8% |
| FY2024 | $117.0M | -42.1% |
| FY2023 | $202.0M | -78.7% |
| FY2022 | $949.0M | -34.1% |
| FY2021 | $1.4B | +2966.0% |
| FY2020 | $47.0M | - |
| FY2019 | $0 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026